← Browse by Condition
Medical Condition

anti n methyl d aspartate receptor encephalitis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06510283 Phase 2
Recruiting

Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis

Enrollment
10 pts
Location
China
Sponsor
Beijing Tongren Hospital
View Trial →